Ameriprise
TVRD

Ameriprise’s Tvardi Therapeutics TVRD Stock Holding History

Ameriprise’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,263
Closed -$87.3K – 3972
2023
Q4 		$87.3K Sell
3,263
-851
-21% -$35.2K ﹤0.01% 3823
2023
Q3 		$249K Hold
4,114
– – ﹤0.01% 3636
2023
Q2 		$419K Sell
4,114
-2,669
-39% -$368K ﹤0.01% 3500
2023
Q1 		$1.2M Sell
6,783
-236
-3% -$79K ﹤0.01% 3074
2022
Q4 		$2.71M Buy
7,019
+1,833
+35% +$696K ﹤0.01% 2668
2022
Q3 		$1.75M Buy
5,186
+185
+4% +$67K ﹤0.01% 2843
2022
Q2 		$1.64M Sell
5,001
-26
-0.5% -$9.12K ﹤0.01% 2889
2022
Q1 		$2.2M Sell
5,027
-301
-6% -$124K ﹤0.01% 2866
2021
Q4 		$2.34M Buy
5,328
+305
+6% +$153K ﹤0.01% 2887
2021
Q3 		$2.79M Sell
5,023
-321
-6% -$161K ﹤0.01% 2727
2021
Q2 		$2.75M Buy
+5,344
New +$3.39M ﹤0.01% 2780
2018
Q4 		– Sell
-2,365
Closed -$2.04M – 3783
2018
Q3 		$2.04M Buy
+2,365
New +$1.71M ﹤0.01% 2812
2017
Q3 		– Sell
-2,231
Closed -$1.24M – 3773
2017
Q2 		$1.24M Sell
2,231
-19
-0.8% -$12.1K ﹤0.01% 2845
2017
Q1 		$1.49M Sell
2,250
-648
-22% -$346K ﹤0.01% 2710
2016
Q4 		$969K Buy
+2,898
New +$930K ﹤0.01% 2984
2015
Q4 		– Sell
-810
Closed -$417K – 3943
2015
Q3 		$417K Buy
+810
New +$542K ﹤0.01% 3345

Other funds holding TVRD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Ameriprise's TVRD Position: Q1 2024 in Review

Ameriprise sold out of Tvardi Therapeutics (TVRD) in Q1 2024, closing a stake of 3,263 shares — an estimated $87.3K sold.

Ameriprise first reported a position in TVRD in Q3 2015 and held it in 16 quarters. The position peaked at $2.79M in Q3 2021. 97 funds tracked by Wall St. Rank hold TVRD as of Q1 2024.

  • Ameriprise reported no remaining Tvardi Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Ameriprise sold 3,263 Tvardi Therapeutics shares in Q1 2024, an estimated $87.3K.
  • Ameriprise first reported a position in Tvardi Therapeutics in Q3 2015 and held it in 16 quarters.
  • Ameriprise's Tvardi Therapeutics position peaked at $2.79M in Q3 2021.
  • 97 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q1 2024.

Based on Ameriprise's 13F filing for Q1 2024, filed 15 May 2024.